Correlation Between Ligand Pharmaceuticals and US Bancorp
Can any of the company-specific risk be diversified away by investing in both Ligand Pharmaceuticals and US Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ligand Pharmaceuticals and US Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ligand Pharmaceuticals General and US Bancorp PERP, you can compare the effects of market volatilities on Ligand Pharmaceuticals and US Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ligand Pharmaceuticals with a short position of US Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ligand Pharmaceuticals and US Bancorp.
Diversification Opportunities for Ligand Pharmaceuticals and US Bancorp
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ligand and USB-PA is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Ligand Pharmaceuticals General and US Bancorp PERP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Bancorp PERP and Ligand Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ligand Pharmaceuticals General are associated (or correlated) with US Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Bancorp PERP has no effect on the direction of Ligand Pharmaceuticals i.e., Ligand Pharmaceuticals and US Bancorp go up and down completely randomly.
Pair Corralation between Ligand Pharmaceuticals and US Bancorp
If you would invest 86,738 in US Bancorp PERP on January 25, 2024 and sell it today you would earn a total of 1,262 from holding US Bancorp PERP or generate 1.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 19.05% |
| Values | Daily Returns |
Ligand Pharmaceuticals General vs. US Bancorp PERP
Performance |
| Timeline |
| Ligand Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
| US Bancorp PERP |
Ligand Pharmaceuticals and US Bancorp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ligand Pharmaceuticals and US Bancorp
The main advantage of trading using opposite Ligand Pharmaceuticals and US Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ligand Pharmaceuticals position performs unexpectedly, US Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Bancorp will offset losses from the drop in US Bancorp's long position.| Ligand Pharmaceuticals vs. Marathon Group Corp | Ligand Pharmaceuticals vs. Halitron | Ligand Pharmaceuticals vs. Icon Media Holdings | Ligand Pharmaceuticals vs. Protext Mobility |
| US Bancorp vs. KeyCorp | US Bancorp vs. Regions Financial | US Bancorp vs. US Bancorp | US Bancorp vs. KeyCorp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |